Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. Shareholder Equity 2015–2022
Aptevo Therapeutics Inc. annual shareholder equity history from 2015 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aptevo Therapeutics Inc. shareholder equity as of December 31, 2022: 18.0M, a 1378.13% increase year-over-year.
- Aptevo Therapeutics Inc. shareholder equity for 2022 were 18.0M, a 1378.13% increase from 2021.
- Aptevo Therapeutics Inc. shareholder equity for 2021 were 1.2M, a 92.67% decrease from 2020.
- Aptevo Therapeutics Inc. shareholder equity for 2020 were 16.6M, a 40.13% increase from 2019.
- Aptevo Therapeutics Inc. shareholder equity for 2019 were 11.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aptevo Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $18 |
| 2021 | $1 |
| 2020 | $17 |
| 2019 | $12 |
| 2018 | $30 |
| 2017 | $82 |
| 2016 | $51 |
| 2015 | $89 |
Aptevo Therapeutics Inc. Shareholder Equity — FAQ
Aptevo Therapeutics Inc. (APVO) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APVO's shareholder equity history?
The chart and table above show Aptevo Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.